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A Functional ABCC11 Allele Is Essential in the
Biochemical Formation of Human Axillary Odor
Annette Martin1,3, Matthias Saathoff1,3, Fabian Kuhn2, Heiner Max1, Lara Terstegen1 and Andreas Natsch2
The characteristic human axillary odor is formed by bacterial action on odor precursors that originate from
apocrine sweat glands. Caucasians and Africans possess a strong axillary odor ,whereas many Asians have only a
faint acidic odor. In this study, we provide evidence that the gene ABCC11 (MRP8), which encodes an apical
efflux pump, is crucial for the formation of the characteristic axillary odor and that a single-nucleotide
polymorphism (SNP) 538G-A, which is prominent among Asian people, leads to a nearly complete loss of the
typical odor components in axillary sweat. The secretion of amino-acid conjugates of human-specific odorants
is abolished in homozygotic carriers of the SNP, and steroidal odorants and their putative precursors are
significantly reduced. Moreover, we show that ABCC11 is expressed and localized in apocrine sweat glands.
These data point to a key function of ABCC11 in the secretion of odorants and their precursors from apocrine
sweat glands. SNP 538G-A, which also determines human earwax type, is present on an extended haplotype,
which has reached 495% frequency in certain populations in recent human evolution. A strong positive
selection in mate choice for low-odorant partners with a dysfunctional ABCC11 gene seems a plausible
explanation for this striking frequency of a loss-of-function allele.
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INTRODUCTION
The human armpit has been named a ‘‘scent organ’’ as it has a
central function in human body odor formation. Apocrine sweat
glands in the axillary region secrete a variety of odor precursors
that are transformed into volatile odoriferous substances by
bacterial enzymes on the skin surface (Natsch et al., 2003, 2005,
2006). The main contributors to axillary odor are (i) unsaturated
or hydroxylated branched fatty acids with (E)-3-methyl-2-
hexenoic acid (3M2H) and 3-hydroxy-3-methyl-hexanoic acid
(HMHA) as key components, (ii) sulfanylalkanols, particularly
3-methyl-3-sulfanylhexan-1-ol (3M3SH) (Hasegawa et al.,
2004; Natsch et al., 2004; Troccaz et al., 2004), and (iii) the
odoriferous steroids, 5a-androst-16-en-3-one and 5a-androst-
16-en-3a-ol, which exhibit a urine- or musk-like smell (Bird
and Gower, 1981). Although the precursors of odorant acids
have been shown to be glutamine conjugates that are cleaved
specifically by a bacterial Na-acyl-glutamine-aminoacylase from
Corynebacterium striatum A20, sulfanylalkanols are secreted
from apocrine sweat glands as cysteine–(S) or cysteine–
glycine–(S) conjugates (Starkenmann et al., 2005; Emter and
Natsch, 2008), and are set free by the sequential action of
a bacterial dipeptidase, tpdA, and a cysteine b-lyase, which
have been cloned from the same bacterial strain (Emter and
Natsch, 2008).
Apocrine sweat contains relatively high amounts of
proteins (Froebe et al., 1990; Jacoby et al., 2004) and
nonodoriferous steroids, for example, dehydroepiandroster-
one (DHEA), androsterone, testosterone, and their corre-
sponding sulfates (Toth and Faredin, 1985). It has been
suggested by several authors that the two odoriferous steroids,
5a-androst-16-en-3-one and 5a-androst-16-en-3a-ol, are
formed from nonodoriferous steroid precursors as a result of
bacterial metabolism (Labows et al., 1979; Gower et al.,
1997; Decreau et al., 2003).
In contrast to the well-characterized influence of skin
microflora and bacterial enzymes on axillary odor formation,
only little is known about the fundamental metabolic and
transport processes occurring in the apocrine sweat gland
leading to the secretion of odorant precursor molecules.
Recently, Yoshiura et al. (2006) showed that gene ABCC11
(MRP8), encoding an ATP-driven efflux pump, has a key role
in the function of ceruminous apocrine glands that are
localized in the auditory canal. The authors reported that a
SNP, 538G-A, in ABCC11, leading to a G180R substitution
in the corresponding protein, provokes a dry and white
earwax phenotype, which is predominant among East Asians
(80–95%) and rare among European and African populations
(0–3%), which normally have a wet and yellow earwax
phenotype. Quite recently, Toyoda et al. (2009) showed that
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the nucleotide polymorphism affects N-linked glycosylation
of ABCC11, resulting in proteasomal degradation of the
variant protein. The SNP in ABCC11 is unique, as it has been
described as the only human SNP determining a visible
genetic trait. Furthermore, it is present on an extended
haplotype, which seems to have risen rapidly in frequency
from a recent founder (Yoshiura et al., 2006), indicating a
strong positive selection for this (or the linked) SNP.
Interestingly, it was previously reported that the character-
istics of earwax are interconnected with the strength of
axillary odor, whereby wet earwax is accompanied by a
strong axillary odor and dry earwax goes along with a missing
axillary odor (Adachi, 1937). The connection of earwax and
axillary odor can be explained by the close relationship
between ceruminous and apocrine sweat glands, both
belonging to apocrine-type glands that share many histolo-
gical and functional features (Stoeckelhuber et al., 2006).
Recently, the ABCC11 genotype was associated with
colostrum secretion as well as osmidrosis (Miura et al.,
2007; Toyoda et al., 2009).
ABCC11 is known to transport a variety of lipophilic
anions (Chen et al., 2005; Kruh et al., 2007), including cyclic
nucleotides, estradiol 17-b-D-glucuronide, steroid sulfates
such as dehydroepiandrosterone sulfate (DHEAS), and
monoanionic bile acids. As many of these metabolites share
similarities with diverse components of axillary apocrine
sweat, we hypothesized that ABCC11 may have an important
role in the transport processes of apocrine odor molecules
and that the above mentioned SNP in the ABCC11 gene may
lead to a loss of the secretion of metabolites that normally are
essential for the formation of typical axillary odor. To verify
this hypothesis, we carried out a detailed chemical analysis of
axillary sweat samples from 25 subjects of different ABCC11
genotypes. Moreover, we demonstrated the expression and
localization of ABCC11 in human apocrine sweat glands.
RESULTS
ABCC11 genotyping and sweat sampling
The ABCC11 genotype (SNP at 538, G-A) of 25 volunteers
was analyzed (Table 1). Among the Asian panelists, most of
whom originated from the Philippines, China, and Korea, 11
AA homozygotes, 5 AG heterozygotes, and 2 GG homo-
zygotes were identified. Five of the seven tested Caucasian
volunteers originating from Germany and Switzerland were
classified as GG homozygotes, whereas only two showed an
AG genotype.
All genotyped panelists were invited for axillary sweat
sampling during a 30-min period of physical exercise on an
exercise machine, during which time they wore sweat-
absorbing cotton pads in their armpits. For each subject,
between 0.39 g and 4.05 g of axillary sweat was sampled and
extracted. The median sweat amounts collected for genotypes
AA (1.28 g), AG (0.9 g), and GG (0.71 g) were not signifi-
cantly different.
To investigate whether there are differences with regard to
axillary microflora between different ABCC11 genotypes, the
diversity and number of axillary bacteria were determined.
Superficial skin scraping samples from the axillary region
were taken from 10 subjects of AA and from 7 subjects of AG/
GG genotype, from which bacterial diversity was analyzed
using the culture-independent DNA fingerprint method of
single-strand conformation polymorphism (SSCP) (Schwieger
and Tebbe, 1998) profiling (AMODIA Bioservices GmbH,
Braunschweig, Germany). The axillary flora of all samples
was found to be a mixture of mainly Staphylococci,
Corynebacteria, and Propionibacteria. However, no statisti-
cal significance could be observed between subjects of
different genotypes (data not shown). Furthermore, the total
number of bacteria in the scraping samples was assessed
using agar plates (COST, aerobic cultivation; Schaedler,
anaerobic cultivation), which showed no significant differ-
ences either (data not shown).
Quantitative analysis of axillary odorant precursors by liquid
chromatography-mass spectrometry
The glutamine conjugates, 3M2H–Gln and HMHA–Gln, as
well as the Cys–Gly–(S) conjugates of 3M3SH (for structures,
see Figure 1), have been described as precursors for key body
odorants earlier (Natsch et al., 2003, 2006; Starkenmann
et al., 2005; Emter and Natsch, 2008). The amount of these
three precursors in axillary sweat from different ABCC11
genotypes was analyzed by liquid chromatography-mass
spectrometry (LC-MS) from the aqueous fraction of sweat
samples (Table 1). All three conjugates were below detection
limit in the samples of all panelists with the AA genotype. By
contrast, in all axillary sweat samples from AG heterozygotes
and GG homozygotes, the Gln conjugates, 3M2H–Gln
(median amount AG: 0.17mmol, median amount GG:
0.16 mmol) and HMHA–Gln (median amount AG: 1.18 mmol,
median amount GG: 0.85mmol), were detected. The Cys–Gly–(S)
conjugate of 3M3SH was above the detection limit for 12 of the
14 AG and GG genotypes, although below the quantification
limit for most samples. These data indicate that ABCC11 is
essential for the secretion of amino-acid conjugates of relevant
axillary odorants.
Quantitative analysis of enzyme-released odorants from axillary
sweat samples
To further investigate the impact of different ABCC11
genotypes on human axillary odor, the aqueous fractions
of all axillary sweat samples were digested using enzymes
Na-acyl-glutamine-aminoacylase, cysteine b-lyase, and di-
peptidase, tpdA, from the skin isolate, Corynebacterium
striatum A20, to release the axillary odorants from their
nonodoriferous conjugates (Table 2). Subsequently, odorants
were analyzed using two-dimensional GC coupled with time-
of-flight mass spectrometry (GCGC-ToF MS). The branched
acids released by Na-acyl-glutamine aminoacylase were
present below the detection limit (analyte B3) or at very
low levels (analytes A2 and E1) in genotype AA. These results
are consistent with the fact that the Gln conjugates of these
acids were below detection limit in the LC-MS analysis
(Table 1). The same pattern as for branched acids could be
shown for the straight acid C3, but the difference was less
pronounced for the minor analyte C1. Detailed results of a
larger series of enzyme-released acids, most of which were
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under detection level for AA homozygotes, are shown in
the supplementary information (Supplementary Table S1).
The enzyme-released thiol compound, 3M3SH, was found in
six of eight GG panelists and in one of six AG panelists,
but it was not detectable in AA homozygotes (data
not shown).
Table 1. Amino-acid conjugates of key human body odorants in sweat samples of panelists with different
genotypes, determined by LC-MS
Secreted amino-acid conjugates (lmol/2 pads)
Genotype
ABCC11 Sex Age
Ethnic
population
Net weight
sweat (g)/2 pads HMHA–Gln 3M2H–Gln
Cys–Gly conjugate
of 3M3SH
AA M 29 Filipino 1.58 ND1 ND ND
AA F 43 Chinese 1.28 ND ND ND
AA M 43 Filipino 1.18 ND ND ND
AA F 35 Korean 1.11 ND ND ND
AA F 27 Chinese 2.05 ND ND ND
AA F 47 Filipino 1.10 ND ND ND
AA F 50 Filipino 0.72 ND ND ND
AA F 33 Filipino 2.02 ND ND ND
AA M 28 Hong Kong Chinese 0.60 ND ND ND
AA F 40 Filipino 1.31 ND ND ND
AA F 40 Filipino 1.67 ND ND ND
MEDIAN AA 1.28
AG F 31 Filipino 1.47 1.23 0.17 Detectable, o0.03mmol
AG F 38 Filipino 0.84 1.58 0.23 0.041
AG M 32 Filipino 0.83 0.06 Detectable, o0.03 mmol ND
AG M 37 Filipino 0.59 2.71 0.40 Detectable, o0.03mmol
AG F 25 Thai 0.90 0.89 0.14 Detectable, o0.03mmol
AG M 31 German 1.42 1.18 0.18 0.045
AG F 25 German 1.64 0.54 0.10 Detectable, o0.03mmol
MEDIAN AG 0.90 1.180 0.170
GG F 45 Filipino 1.74 0.77 0.13 Detectable, o0.03mmol
GG F 45 Filipino 0.39 0.75 0.11 Detectable, o0.03mmol
GG F 28 German 0.71 1.30 0.19 0.041
GG F 33 German 1.23 1.12 0.16 0.038
GG M 25 German 0.45 2.65 0.43 0.051
GG F 35 German 0.68 0.34 0.09 Detectable, o0.03mmol
GG M 39 Swiss 4.05 0.85 0.18 ND
MEDIAN GG 0.71 0.85 0.160
HMHA, 3-hydroxy-3-methyl-hexanoic acid; LC-MS, liquid chromatography-mass spectrometry; 3M2H; (E)-3-methyl-2-hexenoic acid; 3M3SH: 3-methyl-3-
sulfanylhexan-1-ol.
1ND indicates that no detectable peak is found on the [M+H]+ ion trace of the selected analyte at the correct retention time.
2A detectable peak at the correct retention time is found on [M+H]+ ion trace of the selected analyte, but below quantification limit.
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Figure 1. Structures of the key known human body odor precursors. (a) Na-3-methyl-2-hexenoyl-glutamine (3M2H–Gln). (b) Na-3-methyl-3-hydroxy-hexanoyl-
glutamine (HMHA–Gln). (c) Cys–Gly conjugate of 3-methyl-3-sulfanyl-hexanol (3M3SH).
www.jidonline.org 531
A Martin et al.
ABCC11 and Axillary Odor
Quantitative analysis of free acids in axillary sweat samples
Carboxylic acids, which are present in sweat in an unconju-
gated form, were directly determined from the acidic fraction
of axillary sweat extracts from subjects of different ABCC11
genotypes by gas chromatography-mass spectrometry (GC-MS)
(Table 3a). In Table 3b, the detected amounts of different acids
were normalized to the amounts of hexadecanoic acid, which
is known to be one of the main components of stratum
corneum lipids. Interestingly, the levels of long-chain fatty
acids, hexadecanoic acid, octadecanoic acid, and linolic acid,
are similar between different ABCC11 genotypes (P-va-
lues40.3). The same is true for the short straight-chain fatty
acids, butyric acid, hexanoic acid, and octanoic acid (P-
values40.1), which are odoriferous, although to a much lesser
extent than branched acids. By contrast, the levels of the
odorous branched acids, 3-methyl butyric acid (isovaleric
acid) and 2-methyl butyric acid, are significantly reduced in
sweat samples from AA homozygotes compared with those
from AG and GG genotypes (P-values o0.005).
Analysis of steroid and protein concentration in axillary sweat
samples
The content of the odoriferous steroids, 5a-androst-
16-en-3-one and 5a-androst-16-en-3a-ol, in axillary sweat
was analyzed in the aqueous fraction of extracted sweat samples
by ELISA (Table 4) using a rabbit polyclonal antibody developed
against androstenone-3-(O-carboxymethyl)oxime, which was
coupled to keyhole limpet hemocyanin to induce immunogeni-
city of the relatively small steroid. As protein coupling involved
the oxygen atom at position C3 of the steroid, the antibody
was unable to distinguish between 5a-androst-16-en-3-one and
5a-androst-16-en-3a-ol. Although axillary sweat from GG
homozygotes and AG heterozygotes showed high median
concentrations of the steroids detectable by this ELISA
analysis (median concentration AG: 1070.18ng/ml sweat,
med. conc. GG: 1371.26ng/ml sweat), the concentrations
were significantly reduced in AA homozygotes (med. conc.
AA: 302.16ng/ml sweat; P-value AA versus AG and GG:
P¼ 0.000).
Table 2. Enzyme-released odorants in sweat samples of panelists with different genotypes, determined by
GCGC-ToF MS
lg analyte/2 pads
(median per genotype)
M–W U test
(P-values)
Identifier Structure Name AA AG GG GG and AG
GG and AG
versus AA
A2
O
OHO
3-hydroxy-3-methylhexanoic acid
methyl ester
0.14 44.70 45.82 45.26 0.0000
B3
O
OOH
3-hydroxy-4-methyloctanoic acid
methyl ester
0.00 1.84 0.69 0.75 0.0000
E1
O
O
(E)-3-methyl-2-hexenoic acid
methyl ester
0.02 442.81 442.8 442.8 0.0000
C1
O
OOH
3-hydroxyhexanoic acid
methyl ester
0.03 0.08 0.13 0.12 0.035
C3
O
OOH
3-hydroxyoctanoic acid
methyl ester
0.09 1.29 1.98 1.77 0.0001
GCGC-ToF MS, two-dimensional GC coupled with time-of-flight mass spectrometry.
1This analyte was above the linear range for most of the AG and GG panelists.
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To investigate whether the ABCC11 genotype also has an
impact on metabolites of the apocrine sweat gland that are
non-odoriferous, we quantified the amounts of steroids DHEA
and testosterone from the organic fraction and sulfated
dehydroepiandrosterone (DHEAS) from the aqueous fraction
of axillary sweat samples by ELISA (Table 4). Moreover, we
analyzed the protein concentration in the aqueous fraction of
sweat samples (Table 5). For both DHEA and DHEAS, we
found significantly lower concentrations in samples from AA
homozygotes in comparison with samples from AG and GG
genotypes (DHEA: med. conc. AA: 2.04ng/ml sweat, med.
conc. AG: 94.34ng/ml sweat, med. conc. GG: 131.70ng/ml
sweat; P-value AA versus AG and GG: P¼0.000; DHEAS:
med. conc. AA: 1.85mg/ml sweat, med. conc. AG: 41.36mg/ml
sweat, med. conc. GG: 14.99mg/ml sweat; P-value AA
versus AG and GG P¼0.000). The same could be shown
for protein concentrations (med. conc. AA: 276.79mg/ml
sweat, med. conc. AG: 825.87mg/ml sweat, med. conc.
GG: 1041.31mg/ml sweat; P-value AA versus AG and
GG: P¼0.018; Table 5). By contrast, testosterone levels
were found to be similar in all three genotypes (med.
conc. AA: 0.24ng/ml sweat, med. conc. AG: 0.33ng/ml
sweat, med. conc. GG: 0.46ng/ml sweat; P-value AA versus
AG and GG: P¼ 0.057).
Expression and localization of ABCC11 in apocrine sweat
glands
The expression of the ABCC11 transcript was investigated by
RT–PCR analysis of sweat gland curettage samples from the
armpit of hyperhidrotic patients (Figure 2), which are known
to be rich in apocrine sweat glands (Bechara et al., 2008). As
control tissue, we used face skin from the upper eyelid (below
the eyebrow). Expression of ABCC11 on transcript level was
present only in curettage samples but could not be detected
in control samples from eyelid skin. In contrast, expression of
the housekeeping gene GAPDH was present in both sample
types, suggesting that ABCC11 expression is specific in tissue
containing apocrine sweat glands.
Similar results for ABCC11 expression were obtained by
cDNA microarray analyses (Agilent Whole Human Genome
Oligo Microarrays, Miltenyi Biotec, Bergisch Gladbach,
Germany) of laser-microdissected apocrine sweat glands
using eccrine sweat glands as control tissue for comparison
of gene expression. In apocrine gland tissue, ABCC11
Table 3. (a) Free acids in sweat samples of panelists with different genotypes, absolute values (b) Free acids in
sweat samples of panelists with different genotypes, normalized values
(a) Comparison between genotypes (P-values)
lg/2 pads (median per genotype) Kruskal–Wallis test M–W U test
AA AG GG AG and GG AA versus AG AA versus GG AG versus GG
GG and AG
versus AA
Butyric acid 0.61 0.99 1.27 1.03 0.684 0.221 964 0.338
3-methyl-butyric acid 0.08 0.23 0.76 0.34 0.113 0.002 0.189 0.005
2-methyl-butyric acid 0.23 2.60 12.91 5.64 0.021 0.000 0.094 0.000
Hexanoic acid 1.37 0.85 1.07 0.96 0.390 0.964 0.821 0.603
Octanoic acid 1.38 0.77 1.42 1.04 0.221 0.964 0.684 0.460
Hexadecanoic acid 194.13 138.51 385.43 151.59 0.556 0.258 0.497 0.763
Octadecanoic acid 90.12 45.85 200.09 70.48 0.556 0.298 0.189 0.805
Linoleic acid 18.41 11.93 42.80 13.11 0.618 0.342 0.618 0.805
(b) Comparison between genotypes (P-values)
% of Hexadecanoic acid (median per genotype) Kruskal–Wallis test M–W U test
AA AG GG AG and GG AA versus AG AA versus GG AG versus GG
GG and AG
versus AA
Butyric acid 0.38 0.61 0.35 0.45 0.094 0.751 0.033 0.427
3-Me-Butyric acid 0.07 0.18 0.22 0.22 0.003 0.001 0.160 0.000
2-Me-Butyric acid 0.24 2.47 4.21 3.50 0.001 0.000 0.052 0.000
Hexanoic acid 0.85 0.59 0.52 0.58 0.618 0.063 0.556 0.1627
Octanoic acid 0.88 0.54 0.49 0.54 0.258 0.033 0.497 0.052
Octadecanoic acid 44.95 45.33 53.30 49.55 0.751 0.094 0.258 0.239
Linoleic acid 11.01 11.20 10.70 10.71 0.497 0.342 0.964 0.891
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expression was 1.63-fold above a common reference that was
computed by creating an artificial pool of gene expression
composed of all 22 individual profiles (apocrine and eccrine
samples from 11 donors, data not shown). In eccrine gland
tissue, ABCC11 expression was downregulated 21.40-fold
compared with the above-mentioned common reference
Table 4. Steroid concentrations in sweat of panelists with different genotypes, analyzed by ELISA
ng analyte/ml sweat
(median per genotype)
Kruskal–Wallis test
(P-value)
M–W U
(P-value)
Structure Name AA AG GG
AA versus
AG
AA versus
GG
AG versus
GG
GG and AG
versus AA
5a-androst-16-en-3-one3 302.16 1,070.18 1,371.26 0.016 0.003 1.000 0.000
Testosterone 0.24 0.33 0.46 0.7341 0.0671 0.2601 0.0572
Dehydroepiandrosterone 2.04 94.34 131.70 0.001 0.001 1.000 0.000
lg analyte/ml sweat
(median per genotype)
Dehydroepiandrosterone sulfate 1.85 41.36 14.99 0.002 0.003 1.000 0.000
1Due to normal distribution, a Tukey’s honest significance test for unequal sample sizes was employed.
2Student’s t-test was applied.
3Used antibody is not able to distinguish between 5a-androst-16-en-3-one and 5a-androst-16-en-3a-ol.
Table 5. Protein concentrations in axillary sweat
samples of panelists with different genotypes
lg protein/ml sweat (median per genotype)
AA AG GG AG and GG
276.79 825.87 1041.31 847.66
Kruskal–Wallis test (P-value) M–W U (P-value)
AA versus AG AA versus GG AG versus GG AA versus AG and GG
0.037 0.021 1.000 0.018
cu
1
cu
2
el1 el2 w
ABCC11
GAPDH
500 bp
600 bp
500 bp
600 bp
Figure 2. Reverse transcriptase PCR of ABCC11 in curettage of sweat glands.
A specific ABCC11 PCR product of 556 bp was detected in curettage samples
of human sweat glands (cu1, cu2), whereas in samples from eyelid skin (el1,
el2) no PCR product was amplified. GAPDH expression (amplified PCR
product: 597 bp) was detected in both, curettage and eyelid skin samples.
w: water control.
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(ABCC11 expression differences between apocrine and
eccrine gland tissue as determined by Pavlidis template
matching: P-value¼7.5109).
The localization of ABCC11 protein in apocrine sweat
glands was analyzed by immunohistochemistry of cryosec-
tions from axillary skin samples of a GG homozygote using a
polyclonal antibody against amino acids 929–1144 of the
human ABCC11 protein. Expression of ABCC11 could be
shown within the layer of myoepithelial cells surrounding the
secretory cells of the apocrine coil (Figure 3a). Moreover, a
strong ABCC11 expression was found in single secretory cells
of the apocrine sweat gland, whereas a slight, diffuse signal
was apparent in the apical region of several secretory cells. In
cryosections of axillary skin from AA homozygotes (Figure
3c), the ABCC11 signal was concentrated in the same parts of
apocrine glands as those in GG homozygotes, indicating that
the nonfunctional ABCC11 protein is still translocated to its
site of action. No staining was detected in negative controls
carried out by the omission of the primary antibody (Figure
3b and d). It is noteworthy that apocrine sweat glands in AA
homozygotes showed a slightly different morphology com-
pared with those in GG homozygotes (Figure 3).
DISCUSSION
ABCC11 is crucial for the secretion of odorants and their
precursors from the apocrine sweat gland
The impact of the ABCC11 genotype on the characteristics of
earwax and colostrum was shown previously (Yoshiura et al.,
2006; Miura et al., 2007). By analyzing axillary sweat
samples from different ABCC11 genotypes, we provide
evidence that ABCC11 is directly required for the secretion
of characteristic components contributing to axillary odor
formation. These data indicate that ABCC11 is essential for
the secretion of the amino-acid conjugates 3M2H–Gln,
HMHA—Gln, and Cys–Gly–(S) 3M3SH (Table 1), which are
precursors of the key body odorants, 3M2H, HMHA, and
3M3SH. After enzymatic release from their precursor
molecules, all analyzed branched chain odorants were
significantly reduced in panelists of the AA genotype (Table 2,
Supplementary Table S1). Interestingly, this effect was less
pronounced for the aminoacylase-released straight acids, 3-
hydroxyhexanoic acid and 3-hydroxyheptanoic acid, which
are known as general b-oxidation metabolites and were not
exclusively described as axillary metabolites.
The branched acids, 3-methyl butyric acid and 2-methyl
butyric acid, were also clearly reduced in the AA genotype
(Table 3), indicating that ABCC11 has a high impact on the
secretion of compounds originating from the leucine/iso-
leucine degradation pathway in apocrine sweat glands that
seem to leave the gland as free acids. In contrast, the long and
the short straight-chain acids are not affected by the ABCC11
genotype. They might be secreted by different glands, by an
ABCC11-independent process, or might even be derived from
b-oxidation or bacterial degradation of skin or sebum lipids.
It is very likely that these aliphatic acids are responsible
for a faint sour acidic axillary odor that has been described for
the majority of Japanese volunteers previously (Hasegawa
et al., 2004).
The concentrations of the odoriferous steroids, 5a-androst-
16-en-3-one and 5a-androst-16-en-3a-ol, detected by ELISA
assay, were significantly reduced in panelists of the AA
genotype compared with genotypes AG and GG (Table 4).
a b
c d
Figure 3. Immunolocalization of ABCC11 protein in apocrine sweat glands of different ABCC11 genotypes. (a) GG genotype. Even ABCC11 staining was
detected in myoepithelial cells (-). Moreover, a strong ABCC11 signal was found in single secretory cells ()). Scale bar¼ 20 mm. (b) GG genotype. Negative
control without primary antibody. Scale bar¼20 mm. (c) AA genotype. ABCC11 staining is visible in myoepithelial cells (-) and single secretory cells ()). Scale
bar¼ 20 mm. (d) AA genotype. Negative control without primary antibody. Scale bar¼ 20mm. Blue signal: nuclei stained by Mayer’s hematoxylin;
L: lumen of apocrine sweat gland; reddish brown signal: specific ABCC11 staining.
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Furthermore, it should be noted that the nonodoriferous
androgen, DHEA, and its sulfated derivative, DHEAS, which
are believed to be precursors of the bacterial metabolism
leading to the formation of 5a-androst-16-en-3-one in axillary
sweat (Labows et al., 1979; Gower et al., 1997), were shown
to be reduced in AA genotypes. Several authors have shown
that a functional ABCC11 protein is able to transport DHEAS
(Chen et al., 2005; Bortfeld et al., 2006; Kruh et al., 2007). It
is therefore plausible that a nonfunctional ABCC11 transpor-
ter leads to a strong decrease in DHEAS and DHEA in axillary
apocrine sweat, which in turn might decrease bacterial
production of odoriferous steroids. In contrast to DHEA and
DHEAS, testosterone concentrations were not significantly
reduced in the axillary sweat of AA panelists, suggesting that
ABCC11 has no impact on the transport and metabolism of
sex steroids.
Besides a strong reduction in axillary odor compounds in
sweat samples of AA panelists, the nonfunctional ABCC11
allele leads to a decrease in protein concentration in axillary
sweat (Table 5). This might explain the results recently
published by Jacoby et al. (2004) on apocrine secretion
odor-binding protein 2, one of the proteinaceous components
of apocrine sweat. This protein was shown to be clearly
reduced in axillary sweat samples of Chinese panelists (which
might have been of the AA genotype), but not in panelists of
European, African, and Pakistani descent.
According to literature, ABCC11 possesses broad substrate
specificity for different lipophilic compounds (Guo et al.,
2003; Chen et al., 2005; Kruh et al., 2007), suggesting that
ABCC11 may directly transport lipohilic odorants and
amphiphilic odorant precursors in apocrine sweat glands.
However, it remains to be clarified whether protein
concentrations are affected directly by ABCC11 transport or
by a regulatory function of ABCC11 that finally influences
protein metabolism in the apocrine sweat gland.
Axillary malodor formation is closely linked to the activity
of axillary skin bacteria, mainly Staphylococci and Coryne-
bacteria (Leyden et al., 1981; Natsch et al., 2003, 2005,
2006; Taylor et al., 2003; Troccaz et al., 2004). However, the
marked reduction in odoriferous components in the axillary
sweat of AA haplotypes seems to be independent from the
axillary microflora, which could be shown to be comparable
with one of the subjects with AG and GG genotypes
regarding the amount and diversity of skin bacteria.
ABCC11 is localized in the axillary apocrine sweat gland
The data from RT–PCR, gene–chip analysis, and immunohis-
tological stainings demonstrate that ABCC11 is expressed in
axillary apocrine sweat glands of panelists of wild type
ABCC11 (GG) both at the transcript and at the protein level
(Figure 2 and Figure 3a). Interestingly, in immunohistological
stainings, antibody signal was found in both myoepithelial
cells and secretory cells. Expression of ABCC11 in the
secretory cells of apocrine sweat glands could indicate a
direct function of this transport protein in the process of
apocrine secretion and is consistent with the data on
apocrine sweat compounds being strongly decreased in AA
panelists. An often described, characteristic of the apocrine
secretion process is the release of the apical cell pole
(decapitation) during secretion (Aumuller et al., 1999; Saga,
2001). However, little is known about the molecular
mechanisms of apocrine secretion (Gesase and Satoh,
2003). A very recent publication on ABCC11 expression in
cerumen glands proposed that ABCC11 is localized on
membranes of intracellular granules and vacuoles, where it
transports ceruminous materials for sequestration inside these
compartments (Toyoda et al., 2009). Interestingly, Bang et al.
(1996) described apocrine sweat glands of normal Korean
panelists as being atrophic and small, and without any
signs of decapitation. As in Korea, a high percentage of
the population carries the AA alleles of ABCC11, it is
conceivable that a functional ABCC11 transport protein is
essential not only for the transport of apocrine metabolites
but also for the function and structure of apocrine sweat
glands. Indeed, our microscopic analysis of the apocrine
glands of an AA panelist indicated a slightly different
morphology and a slightly smaller gland size, but with a
detectable ABCC11 expression (Figure 3c). Thus, a dysfunc-
tional ABCC11 secretion process may have a pleiotropic
effect on apocrine glands at the morphological level as well.
The expression of ABCC11 in myoepithelial cells may
suggest that this transport protein also has a role in the supply
of substances for further metabolism from myoepithelial to
secretory cells of the apocrine sweat gland.
Possible evolutionary implications of the ABCC11 mutation
Axillary odor components are believed to have a role in
nonverbal communication between humans, primarily as
alarm (Ackerl et al., 2002; Pause et al., 2004; Prehn et al.,
2006; Mujica-Parodi et al., 2009) or sex pheromones (Cutler
et al., 1986; Pause, 2004; Saxton et al., 2008). Moreover,
signals with regard to individual MHC properties are
supposed to be transmitted by axillary odor (Wedekind
et al., 1995; Wedekind and Furi, 1997; Wedekind and Penn,
2000; Havlicek and Roberts, 2009). According to Yoshiura
et al. (2006), the described SNP in ABCC11 in this study
originated in northeast Asia and then spread rapidly
especially in the Asia-Pacific region. The SNP is mainly
present on a conserved extended haplotype, which has
undergone little recombination, indicating a recent evolu-
tionary origin from a single founder (Yoshiura et al., 2006).
Thus, a high selection pressure must have acted on this
haplotype to reach 495% frequency in large human
populations. This is especially astonishing, as it is a loss-of-
function mutation in a gene that has also been shown to be
expressed in several other tissues such as testis, liver,
placenta, lung, kidney, brain, and axons (Yabuuchi et al.,
2001). Does this selective advantage result from the ‘‘white
earwax’’ phenotype, the change in colostrum contents, the
loss of body odor, or even an unknown phenotypic alteration
due to loss of ABCC11 function in another tissue? Certainly, it
is impossible to decide this question post hoc, yet one may
speculate that in old Eastern cultures with a more pro-
nounced tradition of cleanliness and personal hygiene as
compared to old Western cultures (Benn, 2004), the ‘‘low-
odor-phenotype’’ conferred by a dysfunctional ABCC11
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allele was important in partner selection and gave a mating
advantage to the carriers of the AA genotype. At least from
today’s perspective, with axillary odors being perceived as
socially offensive in Western cultures as well, this explana-
tion for this unique selection pressure seems plausible, and
would be supported by our data proving a crucial function of
a functional ABCC11 allele in the biochemistry of body odor
formation.
MATERIALS AND METHODS
Genotyping
Twenty-five volunteers (5 Asian males, 13 Asian females, 3
Caucasian males, 4 Caucasian females) aged 25–50 years were
genotyped with a focus on position 538 of the gene ABCC11. All
volunteers were informed about the aim and purpose of this study
and were asked to give written consent. Buccal cells were collected
by scraping 10 times over the oral mucosa of the volunteers.
Genomic DNA was purified from the buccal cells using the
Puregene Buccal Cell Core Kit A (Gentra Systems, Minneapolis,
MN) according to the manufacturer’s instructions. PCR amplification
was carried out using primers ABCC11_for (50-GGATTGAAAAAG
CTTCAGTGCT-30) and ABCC11_rev (50-CTAAGTGCCAGGGACAT
GGT-30). The amplified 354-bp fragment was purified using the
QIAquick PCR purification kit (Qiagen, Hilden, Germany) and was
subsequently sequenced using primer ABCC11_for.
Sampling and extraction of axillary secretions
In preparation for sweat sampling, subjects had to abstain from using
deodorant and antiperspirant products for 5 days and used neutral
soap (Baktolin (pH 5.5), Bode Chemie, Hamburg) for washing their
armpits. Axilla secretions of individual donors were sampled on
cotton pads fixed to the axilla during a 30-minute physical exercise
on an exercise machine. During physical exercise, blood pressure
and pulse were controlled regularly. Pads were frozen immediately
after collection and transported to the analysis lab on dry ice. The net
weight of the axilla secretions was determined by weighing fresh
pads and dry pads after extraction. The cotton pads from both
armpits were split into two halves. Two half-pads (one from each
armpit) were pooled in a falcon tube and were extracted with 25ml
20% EtOH in H2O for 20minute. The solution was separated from
the pads by centrifugation and was then extracted using 5ml
cyclohexane. The cyclohexane fraction was amended with 80 ml
isopropanol and concentrated to a final volume of 80ml under a N2
stream. This sample was diluted in 500ml H2O for storage and
subsequent ELISA analysis, and it is referred to as the ‘‘organic
fraction’’.
The aqueous phase after cyclohexane extraction was lyophilized
and re-suspended in 600ml H2O. This is referred to as the ‘‘aqueous
fraction’’ and it was further subjected to protein determination,
ELISA assays, LC-MS analysis and enzymatic digestion for release of
odorants (see below).
To investigate free acids in the fresh sweat, another half-pad was
separately extracted: It was soaked with 3.5ml of HCl (20mM) for
15minute and then the liquid phase was separated by centrifugation.
A total of 2ml diethylether was then added to the same pad, and this
solvent was centrifuged into the same tube. The sample was then
brought to basic pH with 100 ml 1-M NaOH. The organic phase
containing neutral and basic analytes was discarded and the
aqueous phase was acidified with 200 ml 1-M HCl, saturated with
NaCl and extracted with 1ml diethylether. This organic phase
containing the acidic analytes was separated, amended with 50 ml
isopropanol, and concentrated to a final volume of 100 ml under a N2
stream. This sample is referred to as the ‘‘acidic fraction’’.
Analysis for odorant precursors by LC-MS
The aqueous fraction was centrifuged and 5ml of the supernatant was
subjected to LC-MS analysis using the method described by Natsch
et al. (2003). In brief, a Finnigan (ThermoFinnigan, San Jose, CA)
LCQ mass spectrometer operated in the APCI positive mode and
equipped with a Flux Rheos 2000 HPLC pump was used. HPLC
separation was carried out on a C18 RP column modified for
proteins and peptides (VYDAC, Hesperia, CA). A binary eluent
consisting of water (A) and methanol (B) each containing 1% acetic
acid (v/v) was applied at a flow rate of 300 ml/minute. A linear
gradient was applied changing from 10 to 98% B within the
3.5-minute period starting 1minute after injection, then isocratic at
98% B for 4.5minute. Afterwards, the B content was lowered to
10% over 1minute and the column re-equilibrated for 2min.
Calibration solutions of the synthetic samples of 3M2H–Gln (for
synthesis, see Natsch et al., 2003), HMHA–Gln (for synthesis, see
Natsch et al., 2003), and the Cys–Gly–(S) conjugates of 3M3SH
were measured and used for calculating the linearity. Signal areas
were integrated using the extracted mass chromatograms of the
[MþH]þ ions (275 HMHA–Gln; 257 for 3M2H–Gln and 293 for
the Cys–Gly–(S) conjugate of 3M3SH).
Digestion of the aqueous fractions with recombinant enzymes
from Corynebacteria
After LC-MS analysis, the pellet obtained from the aqueous fraction
was re-suspended in the supernatant, and this suspension was used
for further analysis. Part (200ml) of this sample was treated with
1.6 mg of Na-acyl-glutamine-aminoacylase (Natsch et al., 2003),
1.6 mg of cysteine b-lyase (Natsch et al., 2004), and 1.6 mg of
dipeptidase tpdA (Emter and Natsch, 2008). These enzymes were all
cloned from the axilla isolate Corynebacterium striatum A20 and
heterologuously expressed in E. coli. (Natsch et al., 2003, 2004;
Emter and Natsch, 2008), and their involvement in the release of
human body odorants from secreted amino-acid conjugates has been
verified previously (Natsch et al., 2003, 2004; Emter and Natsch,
2008). After 4 h incubation at 36 1C to ensure complete hydrolysis
of the conjugates, the samples were extracted with 30mg NaCl,
17ml HCl (1M) and 100ml methyl-tert-butyl-ether. The organic
phase (80ml) was transferred to a GC vial, 5 ml of a 2M solution
of (trimethylsilyl)-diazomethane (Fluka, Buchs, Switzerland) and
18ml methanol were added, and the sample was heated to
40 1C for 30minute to form methyl esters of the enzymatically
released acids.
GCGC-ToF MS analysis of enzyme-released odorants
The released thiols and the methyl esters of the released acids
were then analyzed using GCGC-ToF MS as described in detail
recently (Kuhn and Natsch, 2008). Following modifications as
compared with the previously used method were applied: sample
volumes of 3ml were injected in the pulsed splitless mode. The inlet
pulse pressure was set to 65.3psi for 4.6minute. A capillary column of
30m length 0.25mm innerdiameter, coated with 0.25mm of VF-5
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MS (5% phenyl-polysiloxane, 95% dimethyl-polysiloxane) was used
for the first-dimension oven (Varian, Palo Alto, CA). Separations were
effected using the following temperature program: 35 1C, isothermal for
5minute, then 10 1C/minute to 120 1C, 5 1C/minute to 210 1C,
then 30 1C/minute to 260 1C, isothermal for 8minute. The modulation
time was 5 seconds. The separate second-dimension oven was kept
at the first-dimension oven temperature, whereas the modulator
housing was kept 15 1C above the first-dimension oven temperature.
Besides the key acids in axilla secretions, 3M2H and HMHA, the
peaks of several other acids were integrated (Kuhn and Natsch,
2008).
GC-MS analysis of free acids in fresh axilla secretions
The ‘‘acidic fraction’’ was analyzed with conventional GC-MS
analysis. A combination of a Hewlett-Packard (Paolo Alto, CA) 5890
II gas chromatograph and a Finnigan MAT SSQ 7000 mass
spectrometer (70 eV EI mode, ion source temperature 180 1C) was
applied. A capillary column of 30m length 0.25mm inner
diameter, coated with 0.25mm of VF-WAXms (polyethylene glycol,
Varian, Palo Alto, CA) was used. Sample volumes of 1.0 ml were
injected in the splitless mode at an injector temperature of 230 1C.
Temperature of the column oven was initially set to 35 1C for
3minute and subsequently increased by 15 1C/minute to 50 1C, then
by 5 1C/minute to 240 1C and then by 10 1C/minute to 250 1C and
held for 60min.
Quantitative analysis of steroids from axillary sweat by ELISA
Quantitative analysis of DHEA, DHEAS and testosterone was done
using ready-to-use ELISAs according to the manufacturer’s instruc-
tions (DHEA Luminescence Immunoassay, DHEA-S ELISA, Testos-
terone Saliva ELISA; IBL, Hamburg, Germany). Test samples for
DHEA and testosterone were taken from the organic fraction of
extracted axillary sweat samples and were tested in repeat
determination (diluted in sample diluent, IBL, Hamburg, Germany;
DHEA: 1:101, testosterone: 1:10). For DHEAS analysis, test samples
were taken from the aqueous fraction (diluted 1:76 in Standard A,
included in the kit, IBL, Hamburg, Germany).
For the concurrent analysis of 5a-androst-16-en-3-one and 5a-
androst-16-en-3a-ol, a polyclonal rabbit antiserum against andros-
tenone-3-(O-carboxymethyl)oxime-keyhole limpet hemocyanin was
used. For competition, androstenone-3-(O-carboxymethyl)oxime–-
horseradish peroxidase was used. Antibody as well as enzyme
conjugate were kindly provided by Dr Hubert Kalbacher (Eberhard
Karls University of Tu¨bingen, Germany). Cross-reactivity of the
antibody against testosterone as well as dehydroepiandrosterone was
excluded by competition experiments (data not shown). The 96-well
microtiter plates were coated with protein A (1 mg/well). Subse-
quently, 100ml of rabbit antiserum (diluted 1:500) was applied to
each well. After several washing steps using 0.002% Tween 20
(Merck, Darmstadt, Germany), 50 ml androstenone enzyme con-
jugate (1mg/ml) and 50 ml of either aqueous phase of extracted sweat
samples (diluted 1:10 in deionized water) or 5a-androst-16-en-3-one
standard (Sigma-Aldrich, Steinheim, Germany) were added to each
well. Incubation was performed at 37 1C for two hours. After
repeated washing, 100ml of ABTS substrate solution (2,20-azino-bis-
(3-ethylbenzthiazoline-6-sulphonic acid; Serva, Heidelberg, Germany)
was added. Absorption was measured at 405nm using the photometer
Safire (Tecan, Crailsheim, Germany).
Determination of protein concentrations in axillary sweat
Determination of protein concentrations from the aqueous fraction
of axillary sweat samples, diluted 1:5 in deinonized water, was
carried out using the BC Assay Protein Quantitation small kit
(Interchim, San Pedro, CA) according to the manufacturer’s
instructions. Absorption was measured at 562 nm using microplate
reader SpectraMAX 250 (Molecular Devices, Sunnyvale, CA).
Axillary punch biopsies and sample preparation
Axillary punch biopsies were taken from four volunteers that had
been tested for their ABCC11 genotype, before. Two volunteers had
an AA genotype whereas the other two were GG homozygotes.
Volunteers were informed about the aim and purpose of the study
and asked to give written informed consent. The study was approved
by the local medical ethics committee (Ethik A¨KHH, Hamburg,
Germany, reference no. 2222, study no. 28406). Axillary skin
samples were obtained by standard punch biopsies with a diameter
of 4mm, following local anaesthesia (Maeverin 1%, Delta Select,
Pfullingen, Germany) and immediately stored on dry ice. Afterwards,
samples that consisted of epidermis, dermis, and subcutaneous
regions of the skin, were frozen by plunging into liquid nitrogen and
stored therein until further processing. Each sample was mounted on
a sample holder using embedding medium (Shandon Cryomatrix,
Thermo Scientific, Waltham, MA, USA) by positioning on its edge to
allow for longitudinal sectioning of the different skin regions
simultaneously. Serial sections (8mm) were cut using a cryostat
(CM3050S, Leica, Wetzlar, Germany), mounted on glass microscope
slides (Superfrost, Fisher Scientific, Schwerte, Germany), air-dried
and fixed in acetone for 20minute at 20 1C in preparation for
staining.
Immunohistochemistry
Sections were rehydrated with Tris-buffered saline (TBS) for
15minute at room temperature and endogenous peroxidase activity
was blocked by treatment with 3% H2O2 for 15minute. In addition,
sections were incubated with avidin D, followed by biotin
incubation for 15minute to inhibit endogenous biotin binding
(Avidin/Biotin Blockin Kit, Vector Laboratories, Burlingame, CA).
Sections were incubated with 10% normal donkey serum
(Jackson Immunoresearch Europe, Suffolk, UK), diluted in TBS
for 20minute to prevent nonspecific antibody binding. Immediately,
sections were incubated with a polyclonal rabbit IgG primary
antibody against amino acids 929–1144 of human ABCC11
(Santa Cruz, Santa Cruz, CA), diluted to 1:100 in TBS, for 18 hour
at 4 1C in a humidity chamber. A donkey biotinylated secondary
antibody (Jackson Immunoresearch Europe, Suffolk, UK), diluted to
1:200 in TBS, was applied to the slides and incubated for 45minute
at room temperature. Signal amplification was achieved using
the avidin–biotin–horseradish peroxidase complex method
(Vectastin ABC Kit, Vector Laboratories, Burlingame, CA), according
to the manufacture’s instruction. Visualization of the immunoreac-
tive sites was carried out using 3-amino-9-ethylcarbazole
(AEC Substrate-Chromogen, DakoCytomation, Glostrup, Denmark).
Between all applications, sections were washed for 15minute
with TBS. The sections were counterstained using Mayer’s hematox-
ylin (Sigma-Aldrich) for 8minute, rehydrated, and coverslipped
using aqueous mounting medium (CV-Ultra, Leica, Wetzlar,
Germany).
538 Journal of Investigative Dermatology (2010), Volume 130
A Martin et al.
ABCC11 and Axillary Odor
Negative controls were carried out by omission of the primary
antibody. Frozen tissue sections of human breast cancer (BioChain,
Hayward, CA) were used as positive controls (data not shown).
RNA extraction and reverse transcriptase PCR
Curettage and upper eyelid (from below the eyebrow) tissue samples
for RT–PCR derived from plastic surgery. Patients gave written
informed consent to further usage of tissue samples for scientific
purpose. Total RNA was isolated from either 70mg of curettage or
eyelid tissue using the RNeasy Fibrous Tissue Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions. RT–PCR
analysis was carried out using a standard reversed two-step
transcription PCR. A total of 750 ng of total RNA was used for
reverse transcription using the High Capacity cDNA Reverse Kit
(Applied Biosystems, Foster City, CA). One-tenth of the reaction
volume was amplified by PCR. The following primers were used for
amplification of ABCC11 and GAPDH cDNAs: ABCC11_
for: 50-GGATTGAAAAAGCTTCAGTGCT-30, ABCC11_rev_2: 50-GT
GTGATGCTGAGCCTTCAC-30 (size of ABCC11 PCR product:
556 bp), GAPDH_for: 50-CCACCCATGGCAAATTCCATGGCA-30,
GAPDH_rev: 50-TCTAGACGGCAGGCAGGTCAGGTCCACC-30
(size of GAPDH PCR product: 597 bp).
Statistical analysis
A Shapiro–Wilk test was used to determine whether the different
datasets were normally distributed or not. In case of normal
distribution, a Tukey’s honest significance test for unequal sample
sizes was used to compare all three genotypes. A Student’s t-test was
applied for a two-group comparison (AA versus AG and GG). After
normal distribution has been excluded, statistical analysis was done
using the Kruskal-Wallis test or the Mann–Whitney U (M-W-U) test
as non-parametric methods.
All studies involving participants were conducted according to
Declaration of Helsinki Principles.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Dr Hubert Kalbacher for kindly providing us with the antibody
against 5a-androst-16-en-3-one and the enzyme conjugate androstenone-
3-(O-carboxymethyl)oxime–horseradish peroxidase. We thank Dr Janina
Lorenz for accomplishing the axillary microflora analysis; Cyrille Claudel
and Philip Drescher for excellent support in the lab; Werner Stauch for
developing and performing sweat extraction methods; Roger Emter for setting
up the ABCC11 genotyping and Hans Gfeller for LC-MS analysis.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Ackerl K, Atzmueller M, Grammer K (2002) The scent of fear. Neuro
Endocrinol Lett 23:79–84
Adachi B (1937) Das Ohrenschmalz als Rassenmerkmal und der Rassenger-
uch (‘‘Achselgeruch’’) nebst dem Rassenunterschied der Schweißdru¨sen.
Z Rassenkunde 6:273–307
Aumuller G, Wilhelm B, Seitz J (1999) Apocrine secretion—fact or artifact?
Anat Anz 181:437–46
Bang YH, Kim JH, Paik SW, Park SH, Jackson IT, Lebeda R (1996)
Histopathology of apocrine bromhidrosis. Plast Reconstr Surg 98:
288–292
Bechara FG, Sand M, Hoffmann K, Boorboor P, Altmeyer P, Stuecker M
(2008) Histological and clinical findings in different surgical strategies
for focal axillary hyperhidrosis. Dermatol Surg 34:1001
Benn CD (2004) China’s Golden Age: Everyday Life During the Tang Dynasty.
Oxford University Press, USA, pp 344
Bird S, Gower DB (1981) The validation and use of a radioimmunoassay for
5[alpha]-androst-16-en-3-one in human axillary collections. J Steroid
Biochem 14:213–9
Bortfeld M, Rius M, Konig J, Herold-Mende C, Nies AT, Keppler D (2006)
Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux
pump for steroid sulfates, is an axonal protein of the CNS and peripheral
nervous system. Neuroscience 137:1247–57
Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD (2005) Transport of bile
acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene
C4 by human multidrug resistance protein 8 (ABCC11). Mol Pharmacol
67:545–57
Cutler WB, Preti G, Krieger A, Huggins GR, Garcia CR, Lawley HJ (1986)
Human axillary secretions influence women’s menstrual cycles: the role
of donor extract from men. Horm Behav 20:463–73
Decreau RA, Marson CM, Smith KE, Behan JM (2003) Production of
malodorous steroids from androsta-5,16-dienes and androsta-4,16-
dienes by Corynebacteria and other human axillary bacteria. J Steroid
Biochem Mol Biol 87:327–36
Emter R, Natsch A (2008) The sequential action of a dipeptidase and a beta-
lyase is required for the release of the human body odorant 3-methyl-3-
sulfanylhexan-1-ol from a secreted Cys-Gly-(S) conjugate by Coryne-
bacteria. J Biol Chem 283:20645–52
Froebe CS, A, Charig A, Eigen E (1990) Axillary malodor production: a new
mechanism. J Soc Cosmet Chem 41:173–85
Gesase AP, Satoh Y (2003) Apocrine secretory mechanism: recent findings
and unresolved problems. Histol Histopathol 18:597–608
Gower DB, Mallet AI, Watkins WJ, Wallace LM, Calame JP (1997) Capillary
gas chromatography with chemical ionization negative ion mass
spectrometry in the identification of odorous steroids formed in
metabolic studies of the sulphates of androsterone, DHA and 5alpha-
androst-16-en-3beta-ol with human axillary bacterial isolates. J Steroid
Biochem Mol Biol 63:81–9
Guo Y, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG et al. (2003)
MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide
efflux pump and a resistance factor for fluoropyrimidines 20,30-
dideoxycytidine and 90-(20-phosphonylmethoxyethyl)adenine. J Biol
Chem 278:29509–14
Hasegawa Y, Yabuki M, Matsukane M (2004) Identification of new odoriferous
compounds in human axillary sweat. Chem Biodivers 1:2042–50
Havlicek J, Roberts SC (2009) MHC-correlated mate choice in humans: a
review. Psychoneuroendocrinology 34:497–512
Jacoby RB, Brahms JC, Ansari SA, Mattai J (2004) Detection and quantification
of apocrine secreted odor-binding protein on intact human axillary skin.
Int J Cosmet Sci 26:37–46
Kruh GD, Guo Y, Hopper-Borge E, Belinsky MG, Chen ZS (2007) ABCC10,
ABCC11, and ABCC12. Pflugers Arch 453:675–84
Kuhn F, Natsch A (2008) Body odour of monozygotic human twins: a
common pattern of odorant carboxylic acids released by a bacterial
aminoacylase from axilla secretions contributing to an inherited body
odour type. J R Soc Interface 6:377–92
Labows JN, Preti G, Hoelzle E, Leyden J, Kligman A (1979) Steroid analysis of
human apocrine secretion. Steroids 34:249–58
Leyden JJ, McGinley KJ, Holzle E, Labows JN, Kligman AM (1981) The
microbiology of the human axilla and its relationship to axillary odor.
J Invest Dermatol 77:413–6
Miura K, Yoshiura K, Miura S, Shimada T, Yamasaki K, Yoshida A et al.
(2007) A strong association between human earwax-type and
apocrine colostrum secretion from the mammary gland. Hum Genet
121:631–3
www.jidonline.org 539
A Martin et al.
ABCC11 and Axillary Odor
Mujica-Parodi L, Strey HH, Frederick B, Savoy R, Cox D, Botanov Y et al.
(2009) Chemosensory cues to conspecific emotional stress activate
amygdala in humans. PLoS One 4:e6415
Natsch A, Derrer S, Flachsmann F, Schmid J (2006) A broad diversity of
volatile carboxylic acids, released by a bacterial aminoacylase from
axilla secretions, as candidate molecules for the determination of
human-body odor type. Chem Biodivers 3:1–20
Natsch A, Gfeller H, Gygax P, Schmid J (2005) Isolation of a bacterial enzyme
releasing axillary malodor and its use as a screening target for novel
deodorant formulations. Int J Cosmet Sci 27:115–22
Natsch A, Gfeller H, Gygax P, Schmid J, Acuna G (2003) A specific bacterial
aminoacylase cleaves odorant precursors secreted in the human axilla. J
Biol Chem 278:5718–27
Natsch A, Schmid J, Flachsmann F (2004) Identification of odoriferous
sulfanylalkanols in human axilla secretions and their formation through
cleavage of cysteine precursors by a C-S lyase isolated from axilla
bacteria. Chem Biodivers 1:1058–72
Pause BM (2004) Are androgen steroids acting as pheromones in humans?
Physiol Behav 83:21–9
Pause BM, Ohrt A, Prehn A, Ferstl R (2004) Positive emotional priming of
facial affect perception in females is diminished by chemosensory
anxiety signals. Chem Senses 29:797–805
Prehn A, Ohrt A, Sojka B, Ferstl R, Pause BM (2006) Chemosensory anxiety
signals augment the startle reflex in humans. Neurosci Lett 394:127–30
Saga K (2001) Histochemical and immunohistochemical markers for human
eccrine and apocrine sweat glands: an aid for histopathologic differentiation
of sweat gland tumors. J Investig Dermatol Symp Proc 6:49–53
Saxton TK, Lyndon A, Little AC, Roberts SC (2008) Evidence that
androstadienone, a putative human chemosignal, modulates women’s
attributions of men’s attractiveness. Horm Behav 54:597–601
Schwieger F, Tebbe CC (1998) A new approach to utilize PCR-single-strand-
conformation polymorphism for 16S rRNA gene-based microbial
community analysis. Appl Environ Microbiol 64:4870–6
Starkenmann C, Niclass Y, Troccaz M, Clark AJ (2005) Identification of the
precursor of (S)-3-methyl-3-sulfanylhexan-1-ol, the sulfury malodour of
human axilla sweat. Chem Biodivers 2:705–16
Stoeckelhuber M, Matthias C, Andratschke M, Stoeckelhuber BM,
Koehler C, Herzmann S et al. (2006) Human ceruminous
gland: ultrastructure and histochemical analysis of antimicrobial and
cytoskeletal components. Anat Rec A Discov Mol Cell Evol Biol 288:
877–84
Taylor D, Daulby A, Grimshaw S, James G, Mercer J, Vaziri S (2003)
Characterization of the microflora of the human axilla. Int J Cosmet Sci
25:137–45
Toth I, Faredin I (1985) Steroids excreted by human skin. II. C19-steroid
sulphates in human axillary sweat. Acta Med Hung 42:21–8
Toyoda Y, Sakurai A, Mitani Y, Nakashima M, Yoshiura KI, Nakagawa H et al.
(2009) Earwax, osmidrosis, and breast cancer: why does one SNP
(538G4A) in the human ABC transporter ABCC11 gene determine
earwax type? FASEB J 23:2001–13
Troccaz M, Starkenmann C, Niclass Y, van de Waal M, Clark AJ (2004)
3-Methyl-3-sulfanylhexan-1-ol as a major descriptor for the human
axilla-sweat odour profile. Chem Biodivers 1:1022–35
Wedekind C, Furi S (1997) Body odour preferences in men and women: do
they aim for specific MHC combinations or simply heterozygosity? Proc
Biol Sci 264:1471–9
Wedekind C, Penn D (2000) MHC genes, body odours, and odour
preferences. Nephrol Dial Transplant 15:1269–71
Wedekind C, Seebeck T, Bettens F, Paepke AJ (1995) MHC-dependent mate
preferences in humans. Proc Biol Sci 260:245–9
Yabuuchi H, Shimizu H, Takayanagi S, Ishikawa T (2001) Multiple splicing
variants of two new human ATP-binding cassette transporters, ABCC11
and ABCC12. Biochem Biophys Res Commun 288:933–9
Yoshiura K, Kinoshita A, Ishida T, Ninokata A, Ishikawa T, Kaname T et al.
(2006) A SNP in the ABCC11 gene is the determinant of human earwax
type. Nat Genet 38:324–30
540 Journal of Investigative Dermatology (2010), Volume 130
A Martin et al.
ABCC11 and Axillary Odor
